• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于溶液的分析方法对A激酶锚定破坏剂进行表征。

Characterization of A-kinase-anchoring disruptors using a solution-based assay.

作者信息

Stokka Anne J, Gesellchen Frank, Carlson Cathrine R, Scott John D, Herberg Friedrich W, Taskén Kjetil

机构信息

Biotechnology Centre of Oslo, University of Oslo, P.O. Box 1125, Blindern, 0317 Oslo, Norway.

出版信息

Biochem J. 2006 Dec 15;400(3):493-9. doi: 10.1042/BJ20060962.

DOI:10.1042/BJ20060962
PMID:16948636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1698590/
Abstract

Subcellular localization of PKA (cAMP-dependent protein kinase or protein kinase A) is determined by protein-protein interactions between its R (regulatory) subunits and AKAPs (A-kinase-anchoring proteins). In the present paper, we report the development of the Amplified Luminescent Proximity Homogeneous Assay (AlphaScreen) as a means to characterize AKAP-based peptide competitors of PKA anchoring. In this assay, the prototypic anchoring disruptor Ht31 efficiently competed in RIIalpha isoform binding with RII-specific and dual-specificity AKAPs (IC50 values of 1.4+/-0.2 nM and 6+/-1 nM respectively). In contrast, RIalpha isoform binding to a dual-specific AKAP was less efficiently competed (IC50 of 156+/-10 nM). Characterization of two RI-selective anchoring disruptors, RIAD (RI-anchoring disruptor) and PV-38 revealed that RIAD (IC50 of 13+/-1 nM) was 20-fold more potent than PV-38 (IC50 of 304+/-17 nM) and did not compete in the RIIalpha-AKAP interaction. We also observed that the kinetics of RII displacement from pre-formed PKA-AKAP complexes and competition of RII-AKAP complex formation by Ht31 differed by an order of magnitude when the component parts were mixed in vitro. No such difference in potency was seen for RIalpha-AKAP complexes. Thus the AlphaScreen assay may prove to be a valuable tool for detailed characterization of a variety of PKA-AKAP complexes.

摘要

蛋白激酶A(cAMP依赖性蛋白激酶或蛋白激酶A)的亚细胞定位由其R(调节)亚基与A激酶锚定蛋白(AKAPs)之间的蛋白质-蛋白质相互作用决定。在本文中,我们报告了一种用于表征基于AKAP的蛋白激酶A锚定肽竞争物的方法——放大发光邻近均相分析(AlphaScreen)的开发。在该分析中,典型的锚定破坏剂Ht31在与RII特异性和双特异性AKAP的RIIα亚型结合中具有高效竞争性(IC50值分别为1.4±0.2 nM和6±1 nM)。相比之下,RIα亚型与双特异性AKAP的结合竞争效率较低(IC50为156±10 nM)。对两种RI选择性锚定破坏剂RIAD(RI锚定破坏剂)和PV - 38的表征显示,RIAD(IC50为13±1 nM)的效力比PV - 38(IC50为304±17 nM)高20倍,并且不参与RIIα - AKAP相互作用的竞争。我们还观察到,当在体外混合各组成部分时,从预先形成的蛋白激酶A - AKAP复合物中置换RII的动力学以及Ht31对RII - AKAP复合物形成的竞争在数量级上有所不同。对于RIα - AKAP复合物,未观察到这种效力差异。因此,AlphaScreen分析可能被证明是详细表征各种蛋白激酶A - AKAP复合物的有价值工具。

相似文献

1
Characterization of A-kinase-anchoring disruptors using a solution-based assay.使用基于溶液的分析方法对A激酶锚定破坏剂进行表征。
Biochem J. 2006 Dec 15;400(3):493-9. doi: 10.1042/BJ20060962.
2
Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding.A激酶锚定蛋白(AKAP)与蛋白激酶A(PKA)调节亚基相互作用的分析:AKAP结合中的PKA亚型特异性
J Mol Biol. 2000 Apr 28;298(2):329-39. doi: 10.1006/jmbi.2000.3662.
3
Isoform specific differences in binding of a dual-specificity A-kinase anchoring protein to type I and type II regulatory subunits of PKA.双特异性A激酶锚定蛋白与蛋白激酶A的I型和II型调节亚基结合的亚型特异性差异。
Biochemistry. 2003 May 20;42(19):5754-63. doi: 10.1021/bi0265729.
4
Molecular basis of AKAP specificity for PKA regulatory subunits.A激酶锚定蛋白(AKAP)对蛋白激酶A(PKA)调节亚基特异性的分子基础。
Mol Cell. 2006 Nov 3;24(3):383-95. doi: 10.1016/j.molcel.2006.09.006.
5
Distribution of regulatory subunits of protein kinase A and A kinase anchor proteins (AKAP 95, 150) in rat pinealocytes.蛋白激酶A调节亚基及A激酶锚定蛋白(AKAP 95、150)在大鼠松果体细胞中的分布
Cell Tissue Res. 2002 Dec;310(3):331-8. doi: 10.1007/s00441-002-0633-9. Epub 2002 Oct 2.
6
Peptides for disruption of PKA anchoring.用于破坏蛋白激酶A锚定的肽段。
Biochem Soc Trans. 2006 Aug;34(Pt 4):472-3. doi: 10.1042/BST0340472.
7
Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2.利用 PKA:AKAP 肽抑制剂 STAD-2 的类似物研究 PKA-RII 的特异性。
Bioorg Med Chem. 2018 Mar 15;26(6):1174-1178. doi: 10.1016/j.bmc.2018.02.001. Epub 2018 Feb 12.
8
High-affinity AKAP7delta-protein kinase A interaction yields novel protein kinase A-anchoring disruptor peptides.高亲和力的A激酶锚定蛋白7δ-蛋白激酶A相互作用产生新型蛋白激酶A锚定破坏肽。
Biochem J. 2006 Jun 1;396(2):297-306. doi: 10.1042/BJ20051970.
9
The effects of disruption of A kinase anchoring protein-protein kinase A association on protein kinase A signalling in neuroendocrine melanotroph cells of Xenopus laevis.破坏A激酶锚定蛋白与蛋白激酶A的结合对非洲爪蟾神经内分泌黑素细胞中蛋白激酶A信号传导的影响。
J Neuroendocrinol. 2006 Jul;18(7):477-83. doi: 10.1111/j.1365-2826.2006.01439.x.
10
Alpha4 integrins are type I cAMP-dependent protein kinase-anchoring proteins.α4整合素是I型环磷酸腺苷依赖性蛋白激酶锚定蛋白。
Nat Cell Biol. 2007 Apr;9(4):415-21. doi: 10.1038/ncb1561. Epub 2007 Mar 18.

引用本文的文献

1
Role of plasma membrane-associated AKAPs for the regulation of cardiac I current by protein kinase A.质膜相关A激酶锚定蛋白在蛋白激酶A对心脏I电流调节中的作用
Naunyn Schmiedebergs Arch Pharmacol. 2017 May;390(5):493-503. doi: 10.1007/s00210-017-1344-9. Epub 2017 Mar 22.
2
Targeting protein-protein interactions in complexes organized by A kinase anchoring proteins.靶向由A激酶锚定蛋白组织的复合物中的蛋白质-蛋白质相互作用。
Front Pharmacol. 2015 Sep 8;6:192. doi: 10.3389/fphar.2015.00192. eCollection 2015.
3
Therapeutic strategies for anchored kinases and phosphatases: exploiting short linear motifs and intrinsic disorder.锚定激酶和磷酸酶的治疗策略:利用短线性基序和内在无序性
Front Pharmacol. 2015 Jul 28;6:158. doi: 10.3389/fphar.2015.00158. eCollection 2015.
4
Architectural and functional roles of A kinase-anchoring proteins in cAMP microdomains.A激酶锚定蛋白在cAMP微区中的结构和功能作用。
J Gen Physiol. 2014 Jan;143(1):9-15. doi: 10.1085/jgp.201311020.
5
PTEN directly activates the actin depolymerization factor cofilin-1 during PGE2-mediated inhibition of phagocytosis of fungi.PTEN 在 PGE2 介导的真菌吞噬作用抑制过程中直接激活肌动蛋白解聚因子丝切蛋白 1。
Sci Signal. 2012 Feb 7;5(210):ra12. doi: 10.1126/scisignal.2002448.
6
An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.一种完全特异的 I 型 A 激酶锚定蛋白,可将两个蛋白激酶 A 分子隔离在线粒体。
Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):E1227-35. doi: 10.1073/pnas.1107182108. Epub 2011 Nov 14.
7
Optic atrophy 1 is an A-kinase anchoring protein on lipid droplets that mediates adrenergic control of lipolysis.视神经萎缩 1 是脂滴上的 A 激酶锚定蛋白,介导肾上腺素能对脂肪分解的控制。
EMBO J. 2011 Oct 7;30(21):4371-86. doi: 10.1038/emboj.2011.365.
8
Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of Toll-like receptor signaling in alveolar macrophages.不同的蛋白激酶 A 锚定蛋白在肺泡巨噬细胞中指导前列腺素 E2 调节 Toll 样受体信号。
J Biol Chem. 2011 Mar 18;286(11):8875-83. doi: 10.1074/jbc.M110.187815. Epub 2011 Jan 19.
9
Networking with AKAPs: context-dependent regulation of anchored enzymes.与A激酶锚定蛋白相互作用:锚定酶的上下文依赖性调节
Mol Interv. 2010 Apr;10(2):86-97. doi: 10.1124/mi.10.2.6.
10
AKAP-independent localization of type-II protein kinase A to dynamic actin microspikes.II型蛋白激酶A不依赖A激酶锚定蛋白定位于动态肌动蛋白微刺突。
Cell Motil Cytoskeleton. 2009 Sep;66(9):693-709. doi: 10.1002/cm.20399.

本文引用的文献

1
Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor.使用 RI 锚定破坏剂描绘 I 型蛋白激酶 A 选择性信号转导事件。
J Biol Chem. 2006 Jul 28;281(30):21535-21545. doi: 10.1074/jbc.M603223200. Epub 2006 May 25.
2
Quantification of cAMP antagonist action in vitro and in living cells.体外及活细胞中环磷酸腺苷(cAMP)拮抗剂作用的定量分析。
Eur J Cell Biol. 2006 Jul;85(7):663-72. doi: 10.1016/j.ejcb.2006.01.009. Epub 2006 Mar 10.
3
High-affinity AKAP7delta-protein kinase A interaction yields novel protein kinase A-anchoring disruptor peptides.高亲和力的A激酶锚定蛋白7δ-蛋白激酶A相互作用产生新型蛋白激酶A锚定破坏肽。
Biochem J. 2006 Jun 1;396(2):297-306. doi: 10.1042/BJ20051970.
4
AKAP signalling complexes: focal points in space and time.A激酶附着蛋白信号复合物:时空焦点
Nat Rev Mol Cell Biol. 2004 Dec;5(12):959-70. doi: 10.1038/nrm1527.
5
Localized effects of cAMP mediated by distinct routes of protein kinase A.由蛋白激酶A的不同途径介导的cAMP的局部效应。
Physiol Rev. 2004 Jan;84(1):137-67. doi: 10.1152/physrev.00021.2003.
6
Related protein-protein interaction modules present drastically different surface topographies despite a conserved helical platform.尽管存在保守的螺旋平台,但相关的蛋白质-蛋白质相互作用模块呈现出截然不同的表面拓扑结构。
J Mol Biol. 2003 Jul 25;330(5):1117-29. doi: 10.1016/s0022-2836(03)00552-7.
7
Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring.A激酶锚定蛋白的生物信息学设计——计算机模拟:一种有效的II型蛋白激酶A锚定选择性肽拮抗剂。
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4445-50. doi: 10.1073/pnas.0330734100. Epub 2003 Apr 2.
8
Designing isoform-specific peptide disruptors of protein kinase A localization.设计蛋白激酶A定位的亚型特异性肽干扰剂。
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4072-7. doi: 10.1073/pnas.2628038100. Epub 2003 Mar 19.
9
Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein.PAP7在类固醇生成中的鉴定、定位及功能:一种与外周型苯二氮䓬受体和PKA(RIα)相关的蛋白质
Mol Endocrinol. 2001 Dec;15(12):2211-28. doi: 10.1210/mend.15.12.0736.
10
AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation.A激酶锚定蛋白-Lbc锚定蛋白激酶A并介导Gα12选择性Rho蛋白介导的应力纤维形成。
J Biol Chem. 2001 Nov 23;276(47):44247-57. doi: 10.1074/jbc.M106629200. Epub 2001 Sep 6.